Fungal infections, caused by various fungi, can affect different parts of the body and present a spectrum of illnesses ranging from mild to severe. Common types include superficial infections like ringworm and athlete's foot, as well as more serious systemic infections that can impact internal organs. Risk factors for fungal infections include weakened immune systems, certain medical treatments, and environmental exposures. Candida species are common culprits, causing infections such as thrush and vaginal yeast infections. Aspergillus and Cryptococcus can lead to serious respiratory infections, particularly in immunocompromised individuals. Diagnosis involves clinical assessment and laboratory testing, with treatment varying based on the type and severity of the infection. Antifungal medications, both topical and systemic, are commonly prescribed. However, resistance to antifungal drugs is a growing concern. Preventive measures include maintaining good hygiene, avoiding prolonged exposure to damp environments, and addressing underlying health conditions. Fungal infections highlight the importance of both proper diagnosis and timely, targeted treatment to ensure favorable outcomes. Ongoing research aims to improve diagnostic methods, treatment options, and our understanding of the complex interactions between fungi and the human immune system.
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria